Cell Signaling Technology

MYH (D13D4) Rabbit Monoclonal Antibody

#6248 · $161

100
Citing papers
6.7k
Combined citations
Supplier page Find this product

Research areas

Cancer-related Molecular Pathways13Cell death mechanisms and regulation8MicroRNA in disease regulation8Cancer-related molecular mechanisms research6Mitochondrial Function and Pathology6HER2/EGFR in Cancer Research5Cancer, Hypoxia, and Metabolism5Autophagy in Disease and Therapy5

Papers citing this product

1
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Nature Communications·2017·440 cit.·DOI
2
Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver
Blood·2008·433 cit.·DOI
3
Microglia Protect Neurons against Ischemia by Synthesis of Tumor Necrosis Factor
Journal of Neuroscience·2009·365 cit.·DOI
4
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Blood·2008·216 cit.·DOI
5
Domain-specific Modification of Heparan Sulfate by Qsulf1 Modulates the Binding of the Bone Morphogenetic Protein Antagonist Noggin
Journal of Biological Chemistry·2004·192 cit.·DOI
6
Valproate Administered after Traumatic Brain Injury Provides Neuroprotection and Improves Cognitive Function in Rats
PLoS ONE·2010·189 cit.·DOI
7
3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression
Carcinogenesis·2002·187 cit.·DOI
8
Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer
British Journal of Cancer·2008·155 cit.·DOI
9
The adhesion G protein-coupled receptor GPR56 is a cell-autonomous regulator of oligodendrocyte development
Nature Communications·2015·142 cit.·DOI
10
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson’s disease
JCI Insight·2021·136 cit.·DOI